Affiliation: Medical University of Vienna
- Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II)J Widder
Department of Radiotherapy and Radiobiology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Br J Cancer 92:1209-14. 2005..Bowel function was satisfactory after more than 5 years. Local control in primarily resectable rectal cancer after 10 x 2.5 Gy is excellent, warranting further evaluation of this treatment...
- Hyperfractionated accelerated radiochemotherapy (HFA-RCT) with mitomycin C for advanced head and neck cancerJ Widder
Department of Radiotherapy and Radiobiology, Vienna General Hospital, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria
Radiother Oncol 73:173-7. 2004..This treatment is at the edge of local tolerability, but there is a good curative chance even for very advanced localised tumours, provided a complete remission is induced at primary treatment...
- The early response of p53-dependent proteins during radiotherapy in human rectal carcinoma and in adjacent normal tissueA Stift
Department of General Surgery, University Hospital Vienna, 1090 Vienna, Austria
Int J Oncol 23:1269-75. 2003..Further investigations are necessary to elucidate its value as a prognostic marker and potential predictor of therapy responsiveness...